Patents by Inventor Vladimir Sabetsky

Vladimir Sabetsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delivery System for Drug and Cell Therapy
    Publication number: 20110097385
    Abstract: A method of lowering blood glucose in a mammal includes administering orally or by injection or inhalation a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin or other therapeutic agents.
    Type: Application
    Filed: March 4, 2004
    Publication date: April 28, 2011
    Applicant: TTDC BIO L.P.
    Inventor: Vladimir Sabetsky
  • Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 KDA and processes for their preparation
    Patent number: 7781400
    Abstract: A solid or semisolid implant obtainable by providing a liquid composition comprising an aqueous solution of dextran with molecular weight of 1.0-100 kDa and introducing the liquid composition into the body of a mammal, whereby the implant is formed in situ in the body of the mammal. A process for preparing a composition useful for biomedical application, comprising the steps of providing a liquid composition comprising an aqueous solution of dextran having a molecular weight of 1-100 kDa; and bringing the liquid composition to solidify; whereby water is gradually eliminated from the liquid composition during the solidification. A biomedical article prepared from the composition.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: August 24, 2010
    Assignee: BOWS Pharmaceuticals AG
    Inventor: Vladimir A. Sabetsky
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTRAN WITH A MOLECULAR WEIGHT OF 1.0-100 KDA AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20100172950
    Abstract: A solid or semisolid implant obtainable by providing a liquid composition comprising an aqueous solution of dextran with molecular weight of 1.0-100 kDa and introducing the liquid composition into the body of a mammal, whereby the implant is formed in situ in the body of the mammal. A process for preparing a composition useful for biomedical application, comprising the steps of providing a liquid composition comprising an aqueous solution of dextran having a molecular weight of 1-100 kDa; and bringing the liquid composition to solidify; whereby water is gradually eliminated from the liquid composition during the solidification. A biomedical article prepared from the composition.
    Type: Application
    Filed: March 15, 2010
    Publication date: July 8, 2010
    Applicant: The Technology Development Company
    Inventor: Vladimir A. Sabetsky
  • ORAL INSULIN COMPOSITION AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20100166855
    Abstract: A method of lowering blood glucose in a mammal includes orally administering a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin.
    Type: Application
    Filed: March 8, 2010
    Publication date: July 1, 2010
    Inventor: Vladimir SABETSKY
  • ORAL INSULIN COMPOSITION AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20100167985
    Abstract: A method of lowering blood glucose in a mammal includes orally administering a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin.
    Type: Application
    Filed: March 8, 2010
    Publication date: July 1, 2010
    Inventor: Vladimir SABETSKY
  • Pharmaceutical Compositions Comprising Dextran With A Molecular Weight Of 1.0-100 KDA And Processes For Their Preparation
    Publication number: 20090281020
    Abstract: A solid or semisolid implant obtainable by providing a liquid composition comprising an aqueous solution of dextran with molecular weight of 1.0-100 kDa and introducing the liquid composition into the body of a mammal, whereby the implant is formed in situ in the body of the mammal. A process for preparing a composition useful for biomedical application, comprising the steps of providing a liquid composition comprising an aqueous solution of dextran having a molecular weight of 1-100 kDa; and bringing the liquid composition to solidify; whereby water is gradually eliminated from the liquid composition during the solidification. A biomedical article prepared from the composition.
    Type: Application
    Filed: July 28, 2009
    Publication date: November 12, 2009
    Applicant: BOWS PHARMACEUTICALS AG
    Inventor: Vladimir A. SABETSKY
  • Long acting injectable insulin composition and methods of making and using thereof
    Patent number: 7544656
    Abstract: A method of lowering blood glucose in a mammal includes injecting a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin over an extended period of time.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: June 9, 2009
    Assignee: The Technology Development Company, Ltd.
    Inventor: Vladimir Sabetsky
  • Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation
    Publication number: 20080305139
    Abstract: A solid or semisolid implant obtainable by providing a liquid composition comprising an aqueous solution of dextran with molecular weight of 1.0-100 kDa and introducing the liquid composition into the body of a mammal, whereby the implant is formed in situ in the body of the mammal. A process for preparing a composition useful for biomedical application, comprising the steps of providing a liquid composition comprising an aqueous solution of dextran having a molecular weight of 1-100 kDa; and bringing the liquid composition to solidify; whereby water is gradually eliminated from the liquid composition during the solidification. A biomedical article prepared from the composition.
    Type: Application
    Filed: January 17, 2007
    Publication date: December 11, 2008
    Inventor: Vladimir A. Sabetsky
  • Tissue enhancement implant and method
    Publication number: 20070003503
    Abstract: A composition adapted for human tissue enhancement includes crystallized dextran microparticles.
    Type: Application
    Filed: April 20, 2005
    Publication date: January 4, 2007
    Inventor: Vladimir Sabetsky
  • Long acting injectable insulin composition and methods of making and using thereof
    Publication number: 20040234616
    Abstract: A method of lowering blood glucose in a mammal includes injecting a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin over an extended period of time.
    Type: Application
    Filed: March 4, 2004
    Publication date: November 25, 2004
    Applicant: THE TECHNOLOGY DEVELOPMENT COMPANY LTD.
    Inventor: Vladimir Sabetsky
  • Oral insulin composition and methods of making and using thereof
    Publication number: 20040234615
    Abstract: A method of lowering blood glucose in a mammal includes orally administering a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin.
    Type: Application
    Filed: March 4, 2004
    Publication date: November 25, 2004
    Applicant: THE TECHNOLOGY DEVELOPMENT COMPANY LTD.
    Inventor: Vladimir Sabetsky